Pro Medicus Ltd

PME: XASX (AUS)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
!>LOCK|?C>DLOCK|tKN!SY@

Pro Medicus Earnings: Strong Growth but Expectations Are Even Stronger

Pro Medicus’ fiscal 2026 underlying net profit rose 24% to AUD 145 million, with underlying EBIT also up by the same magnitude to AUD 196 million. The board declared a final fully franked DPS of AUD 0.37, up 23%, bringing the full-year total to AUD 0.69. Shares rose around 10%.

Sponsor Center